Wednesday, November 09, 2022 11:43:41 AM
Have you been watching from before they went on break? How was it going?
Recent VERU News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/13/2026 01:19:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 01:09:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:00:07 AM
- Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress • GlobeNewswire Inc. • 05/13/2026 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:10:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:59:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:34:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:20:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:10:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 07:59:51 PM
- Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th • GlobeNewswire Inc. • 05/06/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/16/2026 04:15:18 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/07/2026 08:18:22 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/07/2026 08:11:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:04:22 PM
- Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss • GlobeNewswire Inc. • 03/09/2026 12:30:00 PM
- Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/19/2026 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 03:32:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 12:00:14 PM
- Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress • GlobeNewswire Inc. • 02/11/2026 11:30:00 AM
- Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th • GlobeNewswire Inc. • 02/04/2026 01:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/28/2026 09:07:48 PM
